Ellagic acid normalizes mitochondrial outer membrane permeabilization and attenuates inflammation-mediated cell proliferation in experimental liver cancer

Applied Biochemistry and Biotechnology

Volumn 173, Issue 8, 2014, Pages 2254-2266

  Srigopalram, S ^a   Jayraaj, I A ^b   Kaleeswaran, B ^c   Balamurugan, K ^d   Ranjithkumar, M ^a   Kumar, T Senthil ^a   Park, J I ^a   Nou, I S ^a  

^a Sunchon National University   (South Korea)

^b KONGUNADU ARTS AND SCIENCE COLLEGE   (India)

^c A V V M SRI PUSHPAM COLLEGE   (India)

^d PRIST UNIVERSITY   (India)

Author keywords

Apoptosis; Caspase; Cell proliferation; Diethylnitrosamine; Ellagic acid; Mast cell; Membrane permeability; Mitochondria; PCNA

Indexed keywords

CELL DEATH; CELL PROLIFERATION; CHEMICAL ACTIVATION; DIAGNOSIS; ELLAGIC ACID; MITOCHONDRIA; PATHOLOGY; RATS; TRANSMISSION ELECTRON MICROSCOPY;

CASPASES; DIETHYLNITROSAMINE; MAST CELLS; MEMBRANE PERMEABILITY; PCNA;

DISEASES;

CASPASE 9; CYCLIN D1; CYCLIN E; CYCLIN E1; CYCLINE; ELLAGIC ACID; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; CASPASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; INFLAMMATION; LIVER CANCER; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL OUTER MEMBRANE PERMEABILITY; NONHUMAN; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CELL MEMBRANE PERMEABILITY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; LIVER NEOPLASMS; MITOCHONDRION; WISTAR RAT;

RATTUS;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CYCLIN D1; ELLAGIC ACID; HUMANS; LIVER NEOPLASMS; MALE; MITOCHONDRIA; NF-KAPPA B; RATS; RATS, WISTAR;

EID: 84906303595     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-014-1031-y     Document Type: Article

References (43)

1. Zhao, J. L., Zhao, J., & Jiao, H. J. (2013). Applied Biochemistry and Biotechnology, 172, 784-791.
2. Khan, M. S., Halagowder, D., & Niranjali, S. D. (2011). Food and Chemical Toxicology, 49, 173-178.
3. Ford, N. A., Lashinger, L. M., Allott, E. H., & Hursting, S. D. (2013). Frontiers Oncology, 3, 209.
4. Jakszyn, P. G., Allen, N. E., Barroso, L. L., et al. (2012). Cancer Epidemiology Biomarkers, 21, 547-551.
5. Mittal, G., Brar, A. P., & Soni, G. (2006). Pharmacological Reports, 58, 413-419.
6. Mittal, G., Brar, A. P., & Soni, G. (2006). Pharmacological Reports, 58, 413-419.
7. Sivaramakrishnan, V., & Devaraj, S. N. (2009). Chemico-Biological Interactions, 180, 353-359.
8. Al-Kaseem, M., Al-Assaf, Z., & Karabet, F. (2013). Pharmacology and Pharmacy, 4, 611-618.
9. Lee, L., Wang, K., Li, G., Xie, Z., Wang, Y., Xu, J., et al. (2011). BMC Genomics, 12(S3), 1-13.
10. Kim, J. Y., Ok, E., Kim, Y. J., Choi, K. S., & Kwon, O. (2013). Nutrition Research and Practice, 7(3), 153-159.
11. Umesalma, S., & Sudhandiran, G. (2010). Basic and Clinical Pharmacology and Toxicology, 107, 650-655.
12. Jiang, W., Zhu, Z., McGinley, J. N., Bayoumy, K. E., Manni, A., & Thompson, H. J. (2013). Cancer Research, 72(15), 3795-806.
13. Vanella, L., Giacomo, C. D., Acquaviva, R., Barbagallo, I., Volti, G. L., Cardile, V., et al. (2013). Cancers, 5, 726-738.
14. Pittoni, P., & Colombo, M. P. (2012). Cancer Research, 72, 831-835.
15. Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., et al. (2012). Cancer Cell, 22(4), 438-451.
16. Herszényi, L., Hritz, I., Lakatos, G., Varga, M. Z., & Tulassay, Z. (2012). International Journal of Molecular Sciences, 13, 13240-13263.
17. Srigopalram, S., Ilavenil, S., & Indira, A. J. (2012). Biomedicine and Preventive Nutrition, 2, 1-8.
18. Nelson, L. J., Treskes, P., Howie, A. F., Walker, S. W., Hayes, P. C., & Plevris, J. N. (2013). Scientific Reports, 3, 2735.
19. Ranieri, G., Labriola, A., Achille, G., Florio, G., Zito, A. F., & Grammatica, L. (2002). International Journal of Oncology, 21(6), 1317-1323.
20. Ramakrishnan, G., Elinos-Baaez, C. M., Jagan, S., Augustine, T. A., Kamaraj, S., Anandakumar, P., et al. (2008). Molecular and Cellular Biochemistry, 313(1-2), 53-61.
21. Ramakrishnan, G., Jagan, S., Kamaraj, S., Anandakumar, P., & Devaki, T. (2009). Investigational New Drugs, 27, 233-240.
22. Hassoun, E. A., & Cearfoss, J. (2011). Toxicological and Environmental Chemistry, 93(2), 332-344.
23. Gounaris, E., Erdman, S. E., Restaino, C., Gurish, M. F., Friend, D. S., & Gounari, F. (2007). Proceedings of the National Academy of Sciences of the United States of America, 104(50), 19977-19982.
24. Grizzi, F., Di Caro, G., Laghi, L., Hermonat, P., Mazzola, P., Nquyen, D. D., et al. (2013). Immunity & Ageing, 10(1), 1-10.
25. Hodges, K., Kennedy, L.,Meng, F., Alpini, G., & Francis, H. (2012). Translation of Gastrointestinal Cancer, 1(2), 138-150.
26. Kang, J. S., Kang, H. G., Park, Y. I., Lee, H., Park, K., Lee, Y. S., et al. (2013). Experimental and Therapeutic Medicine, 5, 138-142.
27. Sun, H., Yu, L., Wei, H., & Liu, G. (2012). Journal of Biomedicine & Biotechnology, 2012(584728), 1-9.
28. Qasim, B. J., Ali, H. H., & Hussein, A. G. (2012). Saudi Journal of Gastroenterology, 18, 268-76.
29. Zhao, H., Ho, P. C., Lo, Y. H., Espejo, A., Bedford, M. T., Hung, M. C., et al. (2012). PloS One, 7(e29416), 1-7.
30. Muriel, P. (2009). NF-kB in liver diseases: a target for drug therapy. Journal of Applied Toxicology, 29, 91-100.
31. Holdenrieder, S., & Stieber, P. (2004). Clinical Biochemistry, 37, 605-617.
32. Rusca, N., Dehò, L., Montagner, S., Zielinski, C. E., Sica, A., Sallusto, F., et al. (2012). Molecular and Cellular Biology, 32, 4432-4444.
33. Boström, P., Söderström, M., Palokangas, T., Vahlberg, T., Collan, Y., Carpen, O., et al. (2009). BMC Research Notes, 2(140), 1-8.
34. Thieringer, F. R., Maass, T., Anthon, B., Meyer, E., Schirmacher, P., Longerich, T., et al. (2012). Molecular Carcinogenesis, 51, 439-448.
35. Chantrian, C. F., Henriet, P., Jodele, S., Emonard, H., Feron, O., & Courtoy, P. J. (2006). European Journal of Cancer, 42(3), 310-318.
36. Huang, X. H., Chen, J. S., Wang, Q., Chen, X. L., Wen, L., Chen, L. Z., et al. (2011). The Journal of Pathology, 225(3), 463-472.
37. Partyka, R., Gonciarz, M., Jałowiecki, P., Kokociñska, D., & Byrczek, T. (2012). Medical Science Monitor, 18(4), 130-134.
38. Lo, S. J., Fan, L. C., Tsai, Y. F., Lin, K. Y., Huang, H. L., Wang, T. H., et al. (2013). Hepatology, 57(5), 1893-1905.
39. Yu, J. Q., Bao, W., & Lei, J. C. (2013). Phytotherapy Research, 27, 251-257.
40. Zhang, C. Z., Pan, Y., Cao, Y., Lai, P. B. S., Liu, L., Chen, G. G., & Yun (2012). Journal of PLoS ONE, 7(6), e39870, 1-10.
41. Mahdavi, M., Davoodi, J., Zali, M. R., & Foroumadi, A. (2011). Biomedicine&Pharmacotherapy, 65, 175-182.
42. Wang, N., Feng, Y., Zhu, M., Tsang, C. M., Man, K., Tong, Y., et al. (2010). Berberine Induces Autophagic Cell Death and Mitochondrial Apoptosis in Liver Cancer Cells: The Cellular Mechanism. Journal of Cellular Biochemistry, 111, 1426-1436.
43. Kang, J. H., Zhang, W. Q., Song, W., Shen, D. Y., Li, S. S., Tian, L., et al. (2012). Applied Biochemistry and Biotechnology, 166(4), 942-51.